Risk Factors of Fatigue in Idiopathic Parkinson’s Disease in a Polish Population
Table 2
Descriptive data for patients with PD and all patients and for patients with (FSS ≥ 4) and without (FSS < 4) fatigue separately.
All PD patients
Fatigued patients
Nonfatigued patients
( = 114)
( = 66)
( = 48)
Gender, (%) female
44 (38.6%)
26 (39.4%)
18 (37.5%)
1.0
Age, years
62.2 (10.8)
62.6 (12.2)
61.6 (8.9)
0.58
61 25–80
61 25–80
61 46–78
Education, (%):
Primary
18 (15.8%)
10 (15.2%)
8 (16.7%)
0.98
Vocational
30 (26.3%)
18 (27.3%)
12 (25.0%)
Secondary
40 (35.1%)
22 (33.3%)
18 (37.5%)
Higher
26 (22.8%)
16 (24.2%)
10 (20.8%)
Disease duration, years
12.3 (16.9)
14.7 (19.9)
9.1 (11.3)
0.23
6 0.5–72
7 0.5–72
5.5 0.5–54
UPDRS, score
37.3 (18.9)
39.6 (17.6)
34.2 (20.5)
0.18
32 10–81
37 17–79
28.5 10–81
UPDRS Part III, score
18.2 (8.6)
18.5 (7.7)
17.7 (9.9)
0.47
16 6–36
17 7–36
14.5 6–36
Hoehn and Yahr, stage
2.3 (0.8)
2.5 (0.8)
2.1 (0.8)
0.13
2.5 1–4
2.5 1–4
2.0 1–4
Schwab and Englanda, score
77 (12)
75 (11)
79 (14)
0.12
80 40–100
80 50–90
80 40–100
Rigidity score
1.7 (0.9)
1.6 (0.9)
1.8 (0.8)
0.81
2 0–3
2 0–3
2 0–3
Tremor score
1.5 (1.1)
1.4 (1.0)
1.7 (1.2)
0.40
2 0–4
2 0–3
1.5 0–4
Postural abnormalities score
1.3 (0.6)
1.4 (0.6)
1.1 (0.7)
0.09
1 0–3
1 0–3
1 0–2
Akinesia score
1.9 (0.8)
2.0 (0.7)
1.9 (0.9)
0.88
2 0–3
2 1–3
2 0–3
Dyskinesias, (%)
36 (31.6%)
22 (33.3%)
14 (29.2%)
0.78
Fluctuations, (%)
46 (40.4%)
30 (33.3%)
36 (31.6%)
0.42
Treatment duration, years
5.2 (5.8)
7.0 (5.9)
5.1 (5.3)
0.19
5 0–23
6 0–23
4 0–18
LDE, mg/day
504.4 (393.5)
589.4
387.5
0.10
500 0–2000
(428.6)
(311.1)
BDI, (%):
Normal
70 (61.4%)
38 (57.6%)
32 (66.7%)
0.31
Mild depression
38 (33.3%)
22 (33.3%)
16 (33.3%)
Moderate depression
6 (5.3%)
6 (9.1%)
0 (0%)
Severe depression
0 (0%)
0 (0%)
0 (0%)
ESS, (%):
Normal
94 (82.5%)
54 (81.2%)
40 (83.3%)
0.53
Mild-to-moderate sleep apnea
14 (12.3%)
10 (15.2%)
4 (8.3%)
Severe sleep apnea, ESS > 15
6 (5.3%)
2 (3.0%)
4 (8.3%)
Presence of pain, (%)
42 (36.8%)
26 (39.4%)
16 (33.3%)
0.78
Presence of nycturia, (%)
52 (45.6%)
26 (39.4%)
26 (54.2%)
0.29
The table presents standard deviation (SD) and median (min–max) for measurable variables or numbers, and proportions for nominal variables. Significance of the difference between the patients’ groups with FSS ≥ 4 and FSS < 4; Mann-Whitney test for measurable and rank variables and Fisher’s exact test for nominal variables.
